Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014 Published: Nov 2014 No. of Pages: 76 Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Cryptococcal Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptococcal Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cryptococcal Meningitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Detailed report at: http://www.reportsandintelligence.com/cryptococcal-meningitisglobal-clinical-trials-review-h2-2014-market Table of Content Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Cryptococcal Meningitis 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials and Average Enrollment by Country 8 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials 18 Clinical Trials in E7 Countries by Trial Status 19 Clinical Trials by Phase 20 In Progress Trials by Phase 21 Clinical Trials by Trial Status 22 Clinical Trials by End Point Status 23 Unaccomplished Trials of Cryptococcal Meningitis 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Cryptococcal Meningitis Therapeutics Clinical Trials 28 Prominent Drugs 29 Clinical Trial Profiles 30 Clinical Trial Overview of Top Companies 30 Pfizer Inc. 30 Clinical Trial Overview of Pfizer Inc. 30 TTY Biopharm Company Limited 31 Clinical Trial Overview of TTY Biopharm Company Limited 31 Novartis AG 32 Clinical Trial Overview of Novartis AG 32 Liposome Company, Inc 33 Clinical Trial Overview of Liposome Company, Inc 33 Alkermes Plc 34 Clinical Trial Overview of Alkermes Plc 34 Clinical Trial Overview of Top Institutes / Government 35 The National Institute of Allergy and Infectious Diseases 35 Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 35 St. George's University of London 36 Clinical Trial Overview of St. George's University of London 36 University of Minnesota 37 Clinical Trial Overview of University of Minnesota 37 University of Oxford 38 Clinical Trial Overview of University of Oxford 38 University of Zimbabwe-Parirenyatwa Clinical Research Center 39 Clinical Trial Overview of University of Zimbabwe-Parirenyatwa Clinical Research Center 39 Department of Biotechnology, India 40 Clinical Trial Overview of Department of Biotechnology, India 40 French National Agency for Research on AIDS and Viral Hepatitis 41 Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 41 Five Key Clinical Profiles 42 Appendix 74 Abbreviations 74 Definitions 74 Research Methodology 75 Secondary Research 75 About GlobalData 76 Contact Us 76 Disclaimer 76 Source 76 Get detailed TOC at: http://www.reportsandintelligence.com/cryptococcal-meningitisglobal-clinical-trials-review-h2-2014-market/table-of-contents Contact Us: Deep Joshi 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States Direct: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 Fax: +1 (855) 550-5975 Email us: help@reportsandintelligence.com Web: http://www.reportsandintelligence.com Facebook: https://www.facebook.com/reportsnintelligence

GlobalData's clinical trial report, “Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Cryptococcal Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptococcal Meningitis. Detailed report at: http://www.reportsandintelligence.com/cryptococcal-meningitis-global-clinical-trials-review-h2-2014-market